![](/img/cover-not-exists.png)
PP 31 INT70/09 Phase II study of Pazopanib (PZP) monotherapy for patients (pts) with relapsed/refractory urothelial cancer (UC): updated results of a proof-of-concept trial
A. Necchi, N. Nicolai, C. Ortega, T. Sava, C. Sacco, F. Crippa, C. Morosi, C. Messina, N. Zaffaroni, R. SalvioniVolume:
47
Year:
2011
Language:
english
DOI:
10.1016/s0959-8049(11)72683-1
File:
PDF, 58 KB
english, 2011